MD
MedinCell S.A.
MDCLF · OTC
$34.39 +0.00% (+$0.00)
Market Cap 1.08B €
P/E Ratio -
Div. Yield -
ROE 142.89%
Bulios Fair Price
$23.08
32.9% downside
Current Price
$34.39
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MDCLF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/FCF 3,004.54x
P/S 22.90x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 51.64%
FCF growth N/A
Book val. growth N/A
Profitability
23 /100
Weak Net margin 111.61%
Op. margin 80.65%
FCF margin 0.76%
Quality
37 /100
Average ROE 142.89%
ROA 60.07%
Asset turnover 0.54x
Debt
71 /100
Low Int. coverage -4.13x
Net debt/EBITDA -1.01x
Current ratio 2.88x
Stability
43 /100
Moderate Rev. volatility 126.12%
EPS volatility 29.00%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MDCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christophe Douat
Employees
150
Headquarters
Jacou